June 19, 2020 / 11:34 AM / 24 days ago

BRIEF-Uniqure Says First Two Patients Treated In Phase I/II Clinical Trial Of AMT-130

June 19 (Reuters) - Uniqure NV:

* UNIQURE ANNOUNCES FIRST TWO PATIENTS TREATED IN PHASE I/II CLINICAL TRIAL OF AMT-130 FOR THE TREATMENT OF HUNTINGTON’S DISEASE

* UNIQURE - DATA SAFETY MONITORING BOARD WILL REVIEW DATA ON FIRST TWO PATIENTS AND MAKE A DETERMINATION ABOUT CONTINUED DOSING OF NEXT PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below